Trial site
Iowa Diabetes and Endocrinology Research Center
- 19running trials
- 20closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Obesity22 trials
- Type 2 diabetes19 trials
- Type 1 diabetes7 trials
- Fatty liver disease (MASLD/MASH)5 trials
- Chronic kidney disease3 trials
- Coronary artery disease1 trial
- Cushing's syndrome1 trial
- Heart failure1 trial
- Liver cirrhosis1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 326 trials
- Phase 210 trials
- Phase 42 trials
- Status
- Completed19 trials
- Active, not recruiting9 trials
- Recruiting9 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company31 trials
- Boehringer Ingelheim3 trials
- Carmot Therapeutics, Inc.1 trial
- Endogenex, Inc.1 trial
- Madrigal Pharmaceuticals, Inc.1 trial
- and 2 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes4 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Cushing's syndrome1 recruiting
- Liver cirrhosis1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Completed
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 14 Nov 2026